Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Client, organization or corporation number: 15042
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (145)
Results: 1-50 | Export
  1. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-30
    Posted: 2024-05-15
    Designated public office holders:
    • Ben Chin, Senior Policy Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Economic Development
      •
  2. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-30
    Posted: 2024-05-15
    Designated public office holders:
    • Eshan Naik, Director of Policy, Minister's office | Health Canada (HC)
    • Ophelia John, Senior Policy Advisor, Ministry of Health | Health Canada (HC)
    • Mark Holland, Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
    • Economic Development
      •
  3. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-30
    Posted: 2024-05-15
    Designated public office holders:
    • Rodrigo Arancibia, Director for Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  4. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-23
    Posted: 2024-05-15
    Designated public office holders:
    • Nathanielle Morin, Policy Advisor for Minister Marci Ien, Min. Women and Gender Equality and Youth | House of Commons
    Subject matters:
    • International Relations
      •
  5. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-16
    Posted: 2024-05-15
    Designated public office holders:
    • Jaxson Khan, Sr Policy Advisor, MINISTER OF INNOVATION, SCIENCE AND INDUSTRY | Innovation, Science and Economic Development Canada (ISED)
    • Laurel Chester, Senior Advisor, Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
      •
  6. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-16
    Posted: 2024-05-15
    Designated public office holders:
    • David Dlab, Director of Parliamentary Affairs, Office of Senator Colin Deacon | Senate of Canada
    • Colin Deacon, Senator, Independent Senators Group | Senate of Canada
    Subject matters:
    • Industry
      •
  7. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-15
    Posted: 2024-05-15
    Designated public office holders:
    • Mark Schaan, Senior Assistant Deputy Minister, Strategy and Innovation Policy Sector - Assistant Deputy Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
      •
  8. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-15
    Posted: 2024-05-15
    Designated public office holders:
    • Brian Masse, MP for Windsor West, Ontario and NDP Critic for Innovation, Science and Industry | House of Commons
    Subject matters:
    • Industry
      •
  9. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-15
    Posted: 2024-05-15
    Designated public office holders:
    • Etienne-Rene Massie, Assistant Deputy Minister, Small Business, Tourism and Marketplace Services | Innovation, Science and Economic Development Canada (ISED)
    • Andrea Johnston, Assistant Deputy Minister, Innovation Canada | Innovation, Science and Economic Development Canada (ISED)
    • Francis Bilodeau, Associate Deputy Minister, Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  10. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-11
    Posted: 2024-05-15
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Office of Life Science and Economic Development Canada | Innovation, Science and Economic Development Canada (ISED)
    • Alison McConnell, Deputy Director, Office of Life Science and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Director, Innovation Projects Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  11. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-03-20
    Posted: 2024-04-15
    Designated public office holders:
    • Ophelia John, Senior Policy Advisor, Ministry of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  12. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-02-07
    Posted: 2024-03-15
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director for Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  13. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-01-15
    Posted: 2024-02-15
    Designated public office holders:
    • Ben Chin, Policy Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Economic Development
      •
  14. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Benoit Leduc, Manager, Life Sciences Industries Directorate, Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Director, Innovation Projects Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office - Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
      •
  15. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Abigail Sullivan, Policy Analyst | Health Canada (HC)
    • Christopher Johnstone, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  16. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Suzy McDonald, Associate Deputy Minister | Finance Canada (FIN)
    • Mathew Sajkunovic, Director General, Microeconomic Policy Analysis | Finance Canada (FIN)
    Subject matters:
    • Industry
      •
  17. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Jean-Sebastien Bock, Deputy Chief of Staff and Director of Policy, Office of the Minister of Health | Health Canada (HC)
    • Eshan Naik, Director of Policy, Ministry of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  18. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Sachelle Magloire-Prosper, Director of Operations, Economic and Regional Development Policy | Privy Council Office (PCO)
    • Sarah Bernier, Senior Policy Advisor, Economic and Regional Development Policy | Privy Council Office (PCO)
    • Sebastien Lauzier, Senior Policy Analyst, Economic and Regional Development Policy | Privy Council Office (PCO)
    • Jennifer Miller, Assistant Secretary to the Cabinet, Social Policy Branch | Privy Council Office (PCO)
    Subject matters:
    • Industry
      •
  19. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-12-12
    Posted: 2024-01-29
    Designated public office holders:
    • Erin Schock, Director, National Laboratory | Public Health Agency of Canada (PHAC)
    • Joel Denis, Director General, Medical Countermeasures Programming | Public Health Agency of Canada (PHAC)
    • Cindy Evans, Vice-President, Emergency Management Branch | Public Health Agency of Canada (PHAC)
    • Heather Jeffrey, President | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Industry
      •
  20. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-08
    Posted: 2023-12-15
    Designated public office holders:
    • Marie-Françoise Mégie, Senator | House of Commons
    Subject matters:
    • Health
      •
  21. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-08
    Posted: 2023-12-15
    Designated public office holders:
    • Jean-Sebastien Bock, Deputy Chief of Staff and Director of Policy, Office of the Minister of Health | Health Canada (HC)
    • Shanzae Khan, Regional Advisor, Ministry of Health | Health Canada (HC)
    • Ophelia John, Senior Policy Advisor, Ministry of Health | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  22. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-08
    Posted: 2023-12-15
    Designated public office holders:
    • Ed Morgan, Director General | Health Canada (HC)
    • David Lee, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
      •
  23. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-07
    Posted: 2023-12-15
    Designated public office holders:
    • Corey Tochor, Member of Parliament | House of Commons
    • James Hawkes, Parliamentary Assistant | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  24. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  25. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-06
    Posted: 2023-12-14
    Designated public office holders:
    • Francesco Sorbara, Member of Parliment | House of Commons
    Subject matters:
    • Health
      •
  26. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-09-27
    Posted: 2023-10-12
    Designated public office holders:
    • Peter Schiefke, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  27. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-08-31
    Posted: 2023-09-18
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Associate Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  28. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-08-03
    Posted: 2023-11-02
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  29. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-07-13
    Posted: 2023-08-15
    Designated public office holders:
    • Julie Robert, Director | Data and analytics & Appropriate Prescribing and Use, CDATO | Health Canada (HC)
    • Emmanuelle Lamoureux, Director General Healthcare Strategies, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  30. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-06-06
    Posted: 2023-07-15
    Designated public office holders:
    • Rodrigo Arancibia, Director for Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    • Andy Fillmore, Member of Parliament, Parliamentary Secretary to the Minister of Innovation, Science and Industry | House of Commons
    Subject matters:
    • Economic Development
      •
  31. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-05-17
    Posted: 2023-06-15
    Designated public office holders:
    • Daniel MacDonald, Director General, Drugs for Rare Disease | Health Canada (HC)
    Subject matters:
    • Health
      •
  32. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-04-25
    Posted: 2023-05-15
    Designated public office holders:
    • Bianca Hossain, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Ed Morgan, Director General | Health Canada (HC)
    • Daniel MacDonald, Director General, Drugs for Rare Disease | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  33. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-02-27
    Posted: 2023-05-04
    Designated public office holders:
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    • Peter Fonseca, Member of Parliament | House of Commons
    • Kamal Khera, Minister of Seniors | House of Commons
    Subject matters:
    • Health
      •
  34. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-02-01
    Posted: 2023-03-17
    Designated public office holders:
    • Udita Samuel, Policy Advisor | Prime Minister's Office (PMO)
    • Mark Kachuk, Special Assistant | Prime Minister's Office (PMO)
    • Ben Chin, Policy Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Research and Development
    • Health
      •
  35. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-01-31
    Posted: 2023-02-15
    Designated public office holders:
    • Jean-Sebastien Bock, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    • Sadenga Yeba, Deputy Director of Policy, Ministry of Health | Health Canada (HC)
    • Shanzae Khan, Policy Advisor, Ministry of Health | Health Canada (HC)
    Subject matters:
    • Research and Development
    • Economic Development
      •
  36. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-01-26
    Posted: 2023-02-15
    Designated public office holders:
    • Craoline Menard, Manager | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director for Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  37. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-12-22
    Posted: 2023-01-16
    Designated public office holders:
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
    • Economic Development
      •
  38. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-11-18
    Posted: 2022-12-16
    Designated public office holders:
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
    • Research and Development
      •
  39. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-11-11
    Posted: 2022-12-15
    Designated public office holders:
    • Yash Nanda, Policy Advisor, Deputy Prime Minister's office | Finance Canada (FIN)
    Subject matters:
    • Industry
      •
  40. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-11-04
    Posted: 2022-12-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Industry
      •
  41. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-10-27
    Posted: 2022-12-12
    Designated public office holders:
    • Kasondra White, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
      •
  42. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-09-28
    Posted: 2022-10-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceuticals Management Strategies, Strategic Policy Branch | Health Canada (HC)
    • Michelle Mujoomdar, Director, Specialty Pharmaceuticals, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Research and Development
    • Health
      •
  43. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-28
    Posted: 2022-07-15
    Designated public office holders:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Intellectual Property
    • Health
    • Industry
    • International Trade
    • Science and Technology
      •
  44. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-27
    Posted: 2022-07-15
    Designated public office holders:
    • Nancy Hamzawi, Federal Lead and Assistant Deputy Minister, COVID-19 Testing, Contact Tracing and Data Strategy Secretariat | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Intellectual Property
    • Industry
    • Science and Technology
    • International Trade
    • Health
      •
  45. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-24
    Posted: 2022-07-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceuticals Management Strategies, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  46. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-21
    Posted: 2022-07-15
    Designated public office holders:
    • Jean-Sebastien Bock, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  47. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-01
    Posted: 2022-07-15
    Designated public office holders:
    • Hilary Peirce, Senior Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
    Subject matters:
    • Industry
    • Health
      •
  48. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-17
    Posted: 2022-04-16
    Designated public office holders:
    • Sadenga Yeba, Senior Policy Advisor, Minister Duclos office | Health Canada (HC)
    Subject matters:
    • Health
      •
  49. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-01-26
    Posted: 2022-02-15
    Designated public office holders:
    • Jean-Sébastien Bock, Director of Policy, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  50. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-12-21
    Posted: 2022-01-15
    Designated public office holders:
    • Ed Fast, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Health
    • Research and Development
    • Industry
    • Economic Development
      •
Date Modified: